Locations

We maintain primary operations – including an India corporate office – in Ahmedabad, where five expansive facilities provide wide-ranging oral solid dosage (OSD) and injectables manufacturing, packaging and R&D capabilities. 

In 2022, we expanded our Ahmedabad operations through the acquisition of a 293,000 square foot, world-class injectables manufacturing facility featuring several sterile injectable production lines and advanced capabilities including robotic filling, emulsion, aseptic and lyophilization across large- and small-volume parenterals, vials and bags. 

In Hyderabad, specialized teams deliver oncology products across multiple dosage forms, including liquid vials, lyophilized vials and powder. Amneal also maintains India-based active pharmaceutical ingredient (API) capabilities in Dahej, Rajoda and Vizag. These unique in-house capabilities enable us to develop and supply critical API for several products across our portfolio. 

In addition to these extensive development and production capabilities, Amneal also maintains a commercial sales infrastructure that is supporting our growing India portfolios focused on the hospital, ophthalmic and oncology markets.